Related Experiment Videos
Alzheimer's disease and the aging brain.
1Department of Neurosciences, University of California, San Diego, CA 92093, USA. rterry@ucsd.edu
Journal of Geriatric Psychiatry and Neurology
|August 2, 2006
Summary
Alzheimer's disease, a common dementia, involves synapse loss caused by Abeta oligopeptides. This synapse loss strongly correlates with cognitive decline in aging brains.
Area of Science:
- Neuroscience
- Neuropathology
- Gerontology
Background:
- Dementia affects many older adults, with Alzheimer's disease being the most prevalent form.
- Normal aging involves neuronal shrinkage and significant synapse loss, but not a substantial decrease in total neuron count.
- Alzheimer's disease is characterized by neuritic plaques and neurofibrillary tangles, which correlate with cognitive impairment.
Purpose of the Study:
- To enumerate dementia frequencies and investigate cerebral changes in normal aging versus Alzheimer's disease.
- To identify the primary structural correlates of cognitive decline in aging and Alzheimer's disease.
- To explore the role of amyloid and Abeta oligomers in neuronal damage.
Main Methods:
- Enumeration of dementia type frequencies.
- Confocal microscopy to measure synapse density.
- Correlation analysis between neuropathological findings and cognitive measures.
Main Results:
- Alzheimer's disease accounts for approximately 80% of dementia cases.
- Significant synapse loss occurs during normal aging, independent of total neuronal loss.
- Amyloid is present in plaques, but Abeta oligomers are implicated as the destructive agents, strongly correlating with synapse loss and cognitive decline.
Conclusions:
- Abeta oligopeptides are the likely cause of synapse loss in Alzheimer's disease.
- Synapse loss is the strongest structural correlate of cognitive decline in aging and Alzheimer's disease.
- Understanding these mechanisms is crucial for developing targeted therapies for dementia.